Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

Amro M Hassan,1 Heba A Osman,2 Hasan S Mahmoud,2 Mohammed H Hassan,3 Abdel-Kader A Hashim,4 Hesham H Ameen5 1Tropical Medicine Department, Faculty of Medicine, Al-Azhar University (Assiut Branch), Assiut, Egypt; 2Tropical Medicine and Gastroenterology Department, Faculty of Medicine, South Valley Un...

Full description

Bibliographic Details
Main Authors:	Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AA, Ameen HH
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-06-01
Series:	Infection and Drug Resistance
Subjects:	Directly acting antiviral drugs mixed cryoglobulinemia HCV.
Online Access:	https://www.dovepress.com/sofosbuvir-daclatasvir-improves-hepatitis-c-virus-induced-mixed-cryogl-peer-reviewed-article-IDR

Similar Items

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
by: Hassan AM, et al.
Published: (2019-05-01)

Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
by: Michiko Shimada, et al.
Published: (2017-03-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
by: Michael Duerr, et al.
Published: (2019-02-01)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
by: Andrea Angeletti, et al.
Published: (2019-02-01)

Rapid Virological Response (RVR) of Daclatasvir and Sofosbuvir Plus Ribavirin in Non-Cirrhotic, Treatment-Naive Patients of Hepatitis C Virus Genotype 3
by: Muhammad Sarfraz, et al.
Published: (2018-12-01)

Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia
by: Svetlana Yur'evna Milovanova, et al.
Published: (2011-11-01)

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study
by: Rodolfo Sacco, et al.
Published: (2020-12-01)

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
by: Pol S, et al.
Published: (2016-03-01)

Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (−) Negative in the Serum
by: Małgorzata Sikorska-Wiśniewska, et al.
Published: (2021-06-01)

Genetic Association of Hepatitis C-Related Mixed Cryoglobulinemia: A 10-Year Prospectivestudyof Asians Treated with Antivirals
by: Ming-Ling Chang, et al.
Published: (2021-03-01)

SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient
by: Sara Lo Menzo, et al.
Published: (2018-07-01)

TREATMENT OF HCV INFECTION BY A COMBINATION OF SOFOSBUVIR AND DACLATASVIR
by: Y. O. SHULPEKOVA, et al.
Published: (2017-05-01)

Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta
by: Alaa Eldeen M Hashim, et al.
Published: (2020-01-01)

Extremity Gangrene Caused by HBV-Related Cryoglobulinemia Vasculitis in a Patient with Diabetes – A Case Report
by: Gao Y, et al.
Published: (2021-04-01)

Daclatasvir/Sofosbuvir versus Ledipasvir/Sofosbuvir in Patients with Hepatitis C Virus Infection Genotypes 1 and 3
by: Narjes Shokatpour, et al.
Published: (2020-06-01)

Successful Treatment Using Simeprevir, Sofosbuvir and Rituximab of a Severe Form of Hepatitis C Virus-related Mixed Cryoglobulinemia with Cardiac Involvement
by: Rafael Mahieu, et al.
Published: (2015-11-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant
by: Lluís Castells, et al.
Published: (2017-01-01)

Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes
by: Denisa Bojkova, et al.
Published: (2020-04-01)

REFLECTIONS ABOUT THE CRYOTHERAPY IN THE ACUTE PHASE OF RHEUMATOID ARTHRITIS AND ITS CORRELATIONS WITH THE CRYOGLOBULINEMIA
by: Dahyan Wagner da Silva Silveira, et al.
Published: (2006-11-01)

HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems
by: S Yu Milovanova, et al.
Published: (2018-06-01)

Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren'sdisease
by: V I Vasilyev, et al.
Published: (2004-08-01)

Clinical and pathogenetic value of immune disruptions in manifestation of mixed cryoglobulinemia in patients with chronic hepatitis C
by: O. O. Furyk, et al.
Published: (2018-04-01)

Early onset mixed cryoglobulinemia in hepatitis C
by: Kritika Krishnamurthy, et al.
Published: (2015-01-01)

Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
by: Inas E L-Khedr Mohamed, et al.
Published: (2021-04-01)

Coronary artery bypass grafting in a patient with active idiopathic cryoglobulinemia: revisiting the issue
by: Hafiz Abdul Moiz Fakih, et al.
Published: (2016-02-01)

Schistosomal cryoglobulinemia associated with vasculitis and glomerulonephritis Case report
by: Mohamed M NasrAllah
Published: (2014-08-01)

A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
by: M. Shabani, et al.
Published: (2021-07-01)

Restoration of natural killer cell activity in chronic hepatitis C-infected Egyptian patients treated by sofosbuvir/daclatasvir with or without ribavirin
by: Hamdy M Moustafa, et al.
Published: (2021-01-01)

New insights into HCV-related rheumatologic disorders: A review
by: Patrice Cacoub, et al.
Published: (2017-03-01)

PREVALENCE AND RISK FACTORS IN DEVELOPMENT OF CHRONIC HEPATITIS C-ASSOCIATED CRYOGLOBULINEMIA
by: N. V. Dunaeva, et al.
Published: (2014-07-01)

Cryoglobulinemia and its correlation with clinical extrahepatic manifestations in chronic hepatitis C
by: Joanna Jabłońska, et al.
Published: (2017-12-01)

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
by: Leśniak K, et al.
Published: (2021-07-01)

VIROLOGICAL RESPONSES OF VELPATASVIR/SOFOSBUVIR IN PATIENTS WITH HCV GENOTYPE 3
by: Muhammad Sarfraz, et al.
Published: (2020-03-01)

Cryoglobulinemia as an Initial Manifestation of Underlying Hematological Malignancy: A Rare Occurrence in India
by: Narender Kumar, et al.
Published: (2014-07-01)

Аpplication of plasma proteins cryoheparinoprecipitation method in the treatment of patients with cryoglobulinemia
by: G. Ju. Belinin, et al.
Published: (2020-08-01)

Renal Involvement and HBV Infection Are Common in Chinese Patients With Cryoglobulinemia
by: Wei Bai, et al.
Published: (2021-02-01)

Cryoglobulinemic vasculitis with renal involvement: A historic aspect of the problem
by: N B Gordovskaya, et al.
Published: (2015-06-01)

Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin
by: Saverio G. Parisi, et al.
Published: (2016-08-01)